There's a new drug to prevent Covid-19, but there won't be nearly enough for Americans who are eligible

The government has only contracted for enough doses for less than one-tenth the number of people who are eligible for it.

Related Keywords

New York ,United States ,Johns Hopkins University ,Maryland ,Fort Lauderdale ,Florida ,White House ,District Of Columbia ,Clearwater ,France ,Rochester ,Americans ,America ,French ,Donald Trump ,Scott Gottlieb ,Camille Kotton ,Anthony Fauci ,Joe Biden ,Leah Lipsich ,Diane Barron ,George Yancopolous ,Myron Cohen ,Johns Hopkins ,Chanapa Tantibanchachai ,Lisa Wiest ,Jef Kinney ,Peter Marks ,Brian Boyarsky ,Janet Handal ,Clinton Potter ,Immunocompromised Patient Advocacy Group ,Warnermedia Company ,Pfizer ,Astrazeneca ,University Of North Carolina School Medicine ,While The European Commission ,Us Department Of Health ,Fannie Mae ,Infectious Disease Society Of America ,Human Services ,Us Centers For Disease ,Drug Administration ,Cnn ,Institute For Global Health ,Cable News Network Inc ,Mass General Brigham ,Dorry Segev ,Disease Control ,Cicely Waters ,President Joe Biden ,Biologics Evaluation ,Infectious Disease Society ,Global Health ,Infectious Diseases ,North Carolina School ,New York City ,President Donald Trump ,Transplant Recipients ,Institutional Review ,European Commission ,Emergency Use Authorization ,News Network ,Medicine ,Mmunology ,Harmacology ,Natomy ,Hospital ,Ncology ,Doctor ,Immune System ,Byron Cohen ,Government ,Recipient ,Patient ,